Genuinely amazed OCC is trading down here (buying more on falls myself, but funds tight) again, after the BioHorizons deal and Veritas reiterating (far more neatly) what I and others have been saying for a while on HC. Recent comments show this report still not absorbed by smaller investors.
https://mcusercontent.com/418010b734f74e4d79ccacb45/files/f36818c1-6b34-8cb8-bbe2-38a0f2a6c03b/OCC_180423.pdf
Suggest everyone read this report, if you haven't. I suspect Veritas' DCF modelling will quickly be revised up on ATI vs surgery results too, which are due shortly, that, coupled with the ATI vs corticosteroid RCT collaboration results, will likely eventually lead to an ATI partnership with a USA phase III FDA trial, in my opinion. The tide of autologous cellular therapy approvals and Johnson & Johnson commercial success with Legend's autologous CAR-T Carvykti is being missed by Mr Mkt in my opinion:
OCC popped 50% mid June last year on the surprising BH result. Sellers have no excuse on missing any pop on this one....
Veritas 0.90c valuation, page-5
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.31M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $65.26K | 181.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 56760 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.04pm 28/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |